Search

Your search keyword '"Visser, Leo G"' showing total 593 results

Search Constraints

Start Over You searched for: Author "Visser, Leo G" Remove constraint Author: "Visser, Leo G"
593 results on '"Visser, Leo G"'

Search Results

2. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

3. Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

4. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants

5. A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study

6. Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

10. Diagnostic accuracy of urine biomarkers for urinary tract infection in older women: a case-control study

12. Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial

16. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

17. Assessing West Nile virus (WNV) and Usutu virus (USUV) exposure in bird ringers in the Netherlands: a high-risk group for WNV and USUV infection?

18. Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

20. Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy.

21. Methodology of the joint malaria prevention recommendations of Switzerland, Germany, Belgium and The Netherlands.

24. A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study

25. Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose

26. New Insights Into the Kinetics and Variability of Egg Excretion in Controlled Human Hookworm Infections

30. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

31. Rabies knowledge gaps and risk behaviour in Dutch travellers:An observational cohort study

32. Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole:Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy

33. A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics

34. Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

37. Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection Model

38. Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial.

40. Wound drainage after arthroplasty and prediction of acute prosthetic joint infection

44. Definitions of Urinary Tract Infection in Current Research: A Systematic Review

47. List of Contributors

49. Rapid Response to Remdesivir in Hospitalised COVID-19 Patients:A Propensity Score Weighted Multicentre Cohort Study

50. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON):results from the direct boost group of an open-label, multicentre, randomised controlled trial

Catalog

Books, media, physical & digital resources